
|Articles|July 1, 2003
In Search of Complete Remission
San Francisco - Confirming a diagnosis and individualizing treatment are primary goals in the treatment of patients with cutaneous T cell lymphoma (CTCL), as is striving for complete remission, Eric C. Vonderheid, M.D., said at the annual meeting of the American Academy of Dermatology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
2
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
3
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
4
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
5











